Novo Nordisk India celebrates 100th global anniversary EP News Bureau Feb 17, 2023 Launches a nationwide community-service digital portal for its employees to contribute to society
Biocon Biologics denies bribery allegations EP News Bureau Jun 22, 2022 A statement from the company claimed that besides its employees, all its consultants, suppliers and partners are also bound by a…
Civica aims to launch low-cost insulin in US by 2024 Reuters Mar 4, 2022 Civica, launched in 2018 to make generic drugs, said it would produce three copycat versions of insulin
Eris Lifesciences announces Joint Venture with MJ Biopharm to offer insulin in India EP News Bureau Dec 6, 2021 The 70:30 Joint Venture will primarily engage in marketing and distribution of human and analogue insulin including Aspart,…
Biocon Biologics partners with IDF to improve access to insulins EP News Bureau Feb 16, 2021 The partnership coincides with the start of the centenary celebrations of the discovery of insulin
MSF urges government authorities to include patented drugs in upcoming NLEM Usha Sharma Sep 15, 2020 Also recommends inclusion of different formulations of insulin in the upcoming NLEM
Biocon’s partner Mylan receives favourable ruling from US PTAB on Sanofi’s four device patents for… EP News Bureau Jun 1, 2020 Reportedly, the PTAB also found Sanofi’s proposed amended claims for the ‘486 and ‘844 patents unpatentable.
FDA puts in efforts to help make development of biosimilar and interchangeable insulin products EP News Bureau Nov 26, 2019 Consistent, life-long access to insulin is imperative to patient survival and quality of life, says American pediatrician Adm…
Kiran Mazumdar-Shaw promises reduction in rh-Insulin prices EP News Bureau Sep 27, 2019 The announcement was made at an United Nations General Assembly (UNGA) side meeting on innovation and universal health access…
USFDA issues response letter for new drug application for insulin glargine: Biocon Press Trust of India Sep 2, 2019 As per the USFDA, a Complete Response Letter (CRL) is sent to an applicant if the agency determines that it will not approve the…